News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘LungCancer’ clear

  • By conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.

Tags: LungCancer, TranslationalResearch

  • Jessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.

Tags: Genomics, LungCancer, TargetedTherapy, TranslationalResearch

  • Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.

Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy

  • There's never a bad time to stop smoking. Bruce Johnson, MD, explains the benefits of quitting smoking and offers tips to get started.

Tags: LungCancer, PatientEducation, PatientSupport, Prevention

  • The National Cancer Institute today released initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages.

Tags: LungCancer

  • The study found African Americans are more likely to hold perceptions that could interfere with prevention and treatment and indicate a need for improved public health communication about lung cancer.

Tags: BasicResearch, LungCancer

  • Identifying patients with a specific gene mutation that enables drug resistance, and treating them with a combination of drugs, may produce longer remissions, say researchers.

Tags: EGFR, LungCancer

  • Researchers have halted non-small cell lung tumors resistant to Iressa and Tarceva with a newly constructed compound that may also have fewer side effects.

Tags: DrugResistance, LungCancer

  • Researchers at Boston cancer centers have found that a combination of kinase inhibitors may lead to future treatments for lung cancer, colon cancer, and prostate tumors.

Tags: KinaseInhibitor, LungCancer

  • A collaborative study involving Dana-Farber researchers has unearthed a variety of genetic alterations in lung tumors, more than doubling the number already linked to the disease.

Tags: Genomics, LungCancer

Showing 11-20 of 25 items